Myths vs facts: CYP1A2 and weight loss

A common myth claims that people with a certain CYP1A2 variant ('slow caffeine metabolizers') are inherently worse at losing weight. In reality, CYP1A2 affects how quickly caffeine is broken down, but the evidence for a direct impact on weight loss is weak. Caffeine can modestly boost metabolism and fat oxidation in the short term, regardless of genotype. Some studies suggest slow metabolizers may experience greater blood pressure increases with high caffeine intake, which could be a health concern. However, weight loss depends primarily on calorie balance, physical activity, sleep, and overall diet. Human trials have not consistently shown that fast metabolizers lose more weight with caffeine. Knowing your CYP1A2 status should not be used as a sole guide for diet or supplementation decisions. The evidence is moderate, based on observational and intervention studies with small effect sizes. A genetic test does not replace medical advice.